Key result
Microalbuminuria affects ~71% of non-diabetic, non-hypertensive AMI patients and is linked to more post-infarction complications.
Why the study?
Microalbuminuria is an emerging risk factor in acute myocardial infarction, but its prognostic significance and predictive value for complications in non-diabetic, non-hypertensive patients needed evaluation.
Does microalbuminuria predict complications in non-diabetic, non-hypertensive patients with acute myocardial infarction?
Cross-Sectional (n=100)
Does microalbuminuria predict complications in non-diabetic, non-hypertensive patients with acute myocardial infarction?
Microalbuminuria is a significant prognostic marker for post-myocardial infarction complications even in non-diabetic, non-hypertensive patients.
May flag higher-risk non-diabetic post-MI patients; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND is an emerging risk factor in evaluation of inhospital coronary events and long-term morbidity and mortality patients with acute myocardial infarction. The primary aim of this study is to determine the prognostic significance and the value of microalbuminuria for complications in patients with non-diabetic, non-hypertensive acute myocardial . AND METHODS cross sectional study was done on 100 non-diabetic, non-hypertensive patients admitted for acute myocardial infarction. Spot sample was taken for measuring albumin creatinine ratio. Patients were followed up and observed for complications related acute myocardial infarction like left ventricular dysfunction, cardiac failure, LV clot, recurrence of angina, occurrence of and death for a period of one year. the 100 patients included in the study group 71% had microalbuminuria while 29% were normoalbuminuric. The was statistically significant, and it shows that there is definite association between acute myocardial infarction and . myocardial infarction complications were also higher in the group with microalbuminuria indicating its efficacy as a marker in patients with acute myocardial infarction. is a marker of endothelial dysfunction and its level rises in patients with acute myocardial infarction by various , most prominent being as a part of systemic inflammatory response.
No takes yet. Share an insight, caveat, or question.
Peer Mohamed (2019) conducted a cross-sectional in acute myocardial infarction (n=100). Microalbuminuria vs. Normoalbuminuria was evaluated on Complications related to acute myocardial infarction (left ventricular dysfunction, cardiac failure, LV clot, recurrence of angina, arrhythmias, and death). Microalbuminuria was present in 71% of non-diabetic, non-hypertensive patients with acute myocardial infarction and was associated with a higher rate of post-infarction complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: